Cryo Cell International Inc (CCEL) Financial Statements
Industry: Misc Health & Allied Services (Other) (Services)
In fiscal 2025, Cryo Cell International reported revenue of $31.6M, down 1.3% from $32.0M the year before. Net income was -$2.4M (a -7.7% net margin), or -$0.30 per diluted share. Gross margin was 76.6% and operating margin was 1.5%. Operating activities generated $5.5M of cash, leaving $5.2M of free cash flow. At fiscal year end, Cryo Cell International held $61.7M in total assets against $80.3M in total liabilities, including $319,031 of cash and equivalents.
Open the full interactive Cryo Cell International financials → Quarterly statements, key ratios, valuation history and price charts.
Cryo Cell International Key Stats
| Share Price | $4.30 |
|---|---|
| Market Cap | $34.7M |
| Revenue YoY Growth | -1.3% |
| 52-Week Range | $2.89 – $4.57 |
| Shares Outstanding | 8.1 million (basic, 2026 Q3) |
Cryo Cell International Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $31.1M | $28.9M | $30.3M | $31.3M | $32.0M | $31.6M |
| Cost of Goods Sold | $9.7M | $9.0M | $8.8M | $8.4M | $7.9M | $7.4M |
| Gross Profit | $21.5M | $19.9M | $21.5M | $22.9M | $24.0M | $24.2M |
| Operating Income | $7.7M | $4.0M | $4.0M | -$12.3M | $3.5M | $482,394 |
| Pre-Tax Income | $5.0M | $2.6M | $3.3M | -$13.4M | $2.8M | -$2.3M |
| Income Tax | $1.4M | $527,710 | $547,540 | -$3.8M | $2.4M | $92,232 |
| Net Income | $3.6M | $2.1M | $2.8M | -$9.5M | $402,095 | -$2.4M |
| Diluted EPS | $0.45 | $0.25 | $0.33 | -$1.14 | $0.05 | -$0.30 |
Cryo Cell International Quarterly Results
| 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | |
|---|---|---|---|---|
| Revenue | $7.8M | $7.7M | $7.8M | $7.8M |
| Net Income | -$3.8M | $47,108 | $554,586 | $1.3M |
| Diluted EPS | -$0.47 | $0.01 | $0.07 | $0.16 |
Cryo Cell International Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.4M | $8.3M | $1.7M | $406,067 | $560,960 | $319,031 |
| Current Assets | $18.6M | $15.8M | $9.6M | $9.5M | $12.6M | $11.8M |
| Total Assets | $46.2M | $60.7M | $64.9M | $61.2M | $64.7M | $61.7M |
| Current Liabilities | $16.4M | $21.1M | $19.5M | $20.9M | $21.6M | $19.8M |
| Total Long-Term Debt | $5.9M | $1.9M | $8.7M | $8.6M | $8.5M | $8.4M |
| Total Liabilities | $48.9M | $56.5M | $66.4M | $72.3M | $77.9M | $80.3M |
| Shareholders' Equity | -$2.7M | $4.2M | -$1.5M | -$11.0M | -$13.2M | -$18.6M |
Cryo Cell International Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $8.5M | $7.9M | $8.6M | $8.9M | $6.0M | $5.5M |
| Cash From Investing | $357,485 | -$7.0M | -$15.3M | -$8.1M | -$4.9M | -$975,332 |
| Cash From Financing | -$5.0M | -$3.1M | $147,862 | -$2.1M | -$979,118 | -$4.7M |
| Free Cash Flow | $8.4M | $6.1M | -$3.6M | $2.1M | $3.6M | $5.2M |
Figures from Cryo Cell International's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Cryo Cell International financials page for every line item.
Cryo Cell International Company Profile
| Ticker | CCEL |
|---|---|
| Exchange | NYSE |
| Industry | Misc Health & Allied Services (Other) (Services) |
| Headquarters | Oldsmar, Florida |
| Incorporated in | Delaware |
| Fiscal Year End | November 30 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0000862692 |
Frequently Asked Questions
What was Cryo Cell International's revenue in fiscal 2025?
Cryo Cell International (CCEL) reported revenue of $31.6M for fiscal 2025.
What is Cryo Cell International's annual revenue history?
Cryo Cell International's annual revenue by fiscal year: 2020: $31.1M; 2021: $28.9M; 2022: $30.3M; 2023: $31.3M; 2024: $32.0M; 2025: $31.6M.
What was Cryo Cell International's net income in fiscal 2025?
Cryo Cell International reported net income of -$2.4M for fiscal 2025.
What was Cryo Cell International's earnings per share (EPS) in fiscal 2025?
Cryo Cell International's diluted EPS was -$0.30 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Cryo Cell International generate in fiscal 2025?
Cryo Cell International generated $5.2M of free cash flow in fiscal 2025.
What was Cryo Cell International's revenue last quarter?
In its most recent reported quarter (2026 Q3), Cryo Cell International reported revenue of $7.8M.
How much debt does Cryo Cell International have?
Cryo Cell International reported $8.4M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Cryo Cell International are outstanding?
Cryo Cell International reported a weighted average of 8.1 million basic shares outstanding in 2026 Q3.
What is Cryo Cell International's market cap?
Based on its latest closing price, Cryo Cell International (CCEL) has a market capitalization of about $34.7M.
When does Cryo Cell International's fiscal year end?
Cryo Cell International's fiscal year end, as registered with the SEC, is November 30.
Where is Cryo Cell International headquartered?
Cryo Cell International lists its business address in Oldsmar, Florida in its SEC filings.
Cryo Cell International Competitors & Similar Companies
See all 9 Misc Health & Allied Services (Other) (Services) companies →